ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that ...
An anti-inflammation injectable drug called dupilumab can reduce mucus buildup and improve breathing among asthma patients, a ...
The U.S. Food and Drug Administration has placed a clinical hold on Intellia Therapeutics' two late-stage trials testing an ...
By Dennis Thompson HealthDay ReporterTUESDAY, Oct. 28, 2025 (HealthDay News) — Ketamine might not be effective in treating ...
After Intellia Therapeutics paused a pair of phase 3 trials for its CRISPR therapy in response to a liver safety signal, the ...
Shares of Akebia Therapeutics fell sharply premarket after it abandoned plans for a clinical trial of its anemia treatment in patients not on kidney dialysis following a meeting with the Food and Drug ...
The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.
Intellia Therapeutics temporarily paused patient dosing and screening for trials of its nex-z drug after a patient dosed with the drug reported signs of liver injury. The drug is intended to treat ...
Intellia Therapeutics said on Wednesday that the U.S. Food and Drug Administration has placed a clinical hold on its two late ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback